Liu Shuang, Ren Xiaoxu, Gun Linying, Zhang Qi, Zhang Jin, Zhu Yiming
Zhonghua Er Ke Za Zhi. 2015 Aug;53(8):599-604.
The mainstay of therapy in patients with septic shock is early and aggressive intravenous fluid resuscitation. However the type of intravenous fluid that would be ideal for managing septic shock has been intensely debated. In this study, the authors observed the effects of 3% hypertonic saline solution compared with normal saline solution as early fluid resuscitation in children with septic shock.
In this prospective study, 44 septic shock children seen in the intensive care unit (ICU) of the Children's Hospital Affiliated to Capital Institute of Pediatrics were enrolled from January 2012 to January 2014, of whom 33 were male and 11 were female. Patients were randomly divided into two groups: normal saline group (NS group, 24 patients) and 3% hypertonic saline group (HS group,20 patients). There were no significant differences between the 2 groups of patients in age, gender, pediatric critical illness score (PCIS), oxygenation index (OI = PaO2/FiO2), arterial lactate, initial hemodynamic parameters, serum sodium and treatment at time of admission. Patients in NS group received normal saline guided by standard therapy. Those in HS group received 6 ml/kg 3% hypertonic saline as a single bolus over 10 min to 15 min with a maximum of 2 boluses and other standard therapy. Heart rate (HR), mean arterial blood pressure (MAP), arterial lactate, oxygenation index, urine output, serum sodium, lactate clearance rate, PCIS, fluid infusion volume, vasoactive - inotropic score, mechanical ventilation time , as well as incidence of multiple organ dysfunction syndrome (MODS), and 28 days in - hospital mortality were recorded for all patients.
(1) HR, MAP in both groups were significantly higher after infusion than those on admission. There were no significant difference in HR and MAP at 1h, 3h, 6h and 24h after infusion between NS group and HS group. (2) OI in HS group was significantly higher than that on admission at 3 hours after infusion [(321. 8 ± 50. 7) vs. (296. 5 ± 58. 2) mmHg, t = -2. 50, P = 0. 018 ]), and it was significantly higher at 24 hours after infusion in NS group (325. 7 ± 62. 6) vs. (304. 2 ± 70. 4) mmHg, t = -2.60, P=0.016]. There were no significant differences in OI at 1h, 3h, 6h and 24h after infusion between NS group and HS group. (3) At 1 hour after infusion, serum sodium in HS group was significantly higherthan that in NS group [(138.3 ± 3.8)vs. (135.0 ± 3.5) mmol/L, t=8.77, P=0.005], and then no significant difference at 3h, 6h and 24h after infusion between two groups. (4) At 6 hours and 24 hours after treatment, fluid infusion volume in HS group was markedly less than that in NS group [6 h: (39. 2 13. 9) vs. (60. 8 ± 22. 4) ml/kg, t = 14. 21, P =0. 000; 24 h: (102. 9 ± 27. 7) vs. (130. 6 ± 33. 2 ) ml/kg, t= 8. 85, P = 0. 005]. Urine output had not significant different between the two groups. (5) There were no significant differences in 24h PCIS, 24h lactate clearance rate, vasoactive - inotropic score and mechanical ventilation time between the two groups. The incidence of MODS (80. 0% in HS group, 70. 0% in NS group) and mortality rate(5. 0% in HS group, 8. 3% in NS group) were similar in both groups.
The 3% hypertonic saline was effective as resuscitation fluid in pediatric septic shock with respect to restoration of hemodynamic stability without obvious side effects. Hypertonic saline could more rapidly improve oxygenation and need less fluid infusion volume compared with normal saline.
脓毒性休克患者治疗的主要方法是早期积极的静脉液体复苏。然而,对于脓毒性休克治疗而言理想的静脉输液类型一直存在激烈争论。在本研究中,作者观察了3%高渗盐溶液与生理盐水相比,作为脓毒性休克患儿早期液体复苏的效果。
在这项前瞻性研究中,2012年1月至2014年1月从首都儿科研究所附属儿童医院重症监护病房(ICU)收治的44例脓毒性休克患儿纳入研究,其中男性33例,女性11例。患者随机分为两组:生理盐水组(NS组,24例患者)和3%高渗盐组(HS组,20例患者)。两组患者在年龄、性别、小儿危重病例评分(PCIS)、氧合指数(OI=PaO2/FiO2)、动脉血乳酸、初始血流动力学参数、血清钠及入院时治疗情况方面无显著差异。NS组患者接受标准治疗指导下的生理盐水治疗。HS组患者在10至15分钟内给予6ml/kg的3%高渗盐单次推注,最多2次推注,并给予其他标准治疗。记录所有患者的心率(HR)、平均动脉血压(MAP)、动脉血乳酸、氧合指数、尿量、血清钠、乳酸清除率、PCIS、液体输注量、血管活性-正性肌力评分、机械通气时间,以及多器官功能障碍综合征(MODS)的发生率和28天住院死亡率。
(1)两组输注后HR、MAP均显著高于入院时。NS组和HS组输注后1小时、3小时、6小时和24小时的HR和MAP无显著差异。(2)HS组输注后3小时OI显著高于入院时[(321.8±50.7)与(296.5±58.2)mmHg,t=-2.50,P=0.018],NS组输注后24小时OI显著升高(325.7±62.6)与(304.2±70.4)mmHg,t=-2.60,P=0.016]。NS组和HS组输注后1小时、3小时、6小时和24小时的OI无显著差异。(3)输注后1小时,HS组血清钠显著高于NS组[(138.3±3.8)与(135.0±3.5)mmol/L,t=8.77,P=0.005],两组输注后3小时、6小时和24小时无显著差异。(4)治疗后6小时和24小时,HS组的液体输注量明显少于NS组[6小时:(39.2±13.9)与(60.8±22.4)ml/kg,t=14.21,P=0.000;24小时:(102.9±27.7)与(130.6±33.2)ml/kg,t=8.85,P=0.005]。两组尿量无显著差异。(5)两组24小时PCIS、24小时乳酸清除率、血管活性-正性肌力评分和机械通气时间无显著差异。两组MODS的发生率(HS组80.0%,NS组70.0%)和死亡率(HS组5.0%,NS组8.3%)相似。
3%高渗盐作为复苏液用于小儿脓毒性休克,在恢复血流动力学稳定性方面有效且无明显副作用。与生理盐水相比,高渗盐能更快改善氧合且所需液体输注量更少。